ArticleCurrent organic synthesis2026
One-pot Synthesis of Functionalized Benzimidazole-quinazolinone Derivatives.
Article in Current organic synthesis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
INTRODUCTION/
objectiveQuinazolinone and aldehyde derivatives have emerged as important molecules in recent studies because of their wide spectrum of pharmacological and biological effects. They have recently attracted attention in synthesis and research. Combinatorial synthesis for this type of heterocycle has emerged in the literature over the last decade. In one-pot processes, atypical intermediates often play key roles in the overall transformation. An unusual coupling sequence occurs through nucleophilic addition to an in situ-formed Michael intermediate. This is followed by an electrocyclic cyclization step. Motivated by these findings, we focused on designing a convenient synthetic method for the preparation of benzimidazole-quinazolinone and heteroaryl aldehyde derivatives. This study aimed to create efficient MCR pathways using common starting materials to build benzimidazole and quinazolinone scaffolds.
methodsIn this study, we performed a one-pot, three-component reaction. We reacted 2- aminobenzimidazole, various substituted heteroaryl aldehydes, and dimedone in absolute ethanol. Analytical and spectroscopic data (NMR, GC-MS, IR, and UV) were used to characterize and verify the structures of the synthesized complexes.
resultsThe lead was compound 4a (88% yield). This route enables efficient heterocycle assembly. GC-MS analysis confirmed that compounds 4e and 4f share the same base peak (m/z 266), suggesting a common fragmentation pathway due to structural similarities. DISCUSSION: An efficient one-pot method for the synthesis of benzimidazole[2,1-b]quinazolinone derivatives was developed, avoiding multi-step procedures, and spectroscopic analyses confirmed the successful formation of the target compounds, demonstrating the practicality of the method.
conclusionThe compounds obtained represent promising starting points for structural modification, which could lead to the development of more active quinazoline-based derivatives.
Indexed as
Identifiers
42638381What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.